Found 271 results
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies., Nayar, Utthara, Lu Pin, Goldstein Rebecca L., Vider Jelena, Ballon Gianna, Rodina Anna, Taldone Tony, Erdjument-Bromage Hediye, Chomet Max, Blasberg Ronald, et al. , Blood, 2013 Oct 17, Volume 122, Issue 16, p.2837-47, (2013)
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate., Venturutti, Leandro, Teater Matt, Zhai Andrew, Chadburn Amy, Babiker Leena, Kim Daleum, Béguelin Wendy, Lee Tak C., Kim Youngjun, Chin Christopher R., et al. , Cell, 2020 Jul 23, Volume 182, Issue 2, p.297-316.e27, (2020)
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis., Dominguez, Pilar M., Ghamlouch Hussein, Rosikiewicz Wojciech, Kumar Parveen, Béguelin Wendy, Fontan Lorena, Rivas Martín A., Pawlikowska Patrycja, Armand Marine, Mouly Enguerran, et al. , Cancer Discov, 2018 Dec, Volume 8, Issue 12, p.1632-1653, (2018)
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation., Moran-Crusio, Kelly, Reavie Linsey, Shih Alan, Abdel-Wahab Omar, Ndiaye-Lobry Delphine, Lobry Camille, Figueroa Maria E., Vasanthakumar Aparna, Patel Jay, Zhao Xinyang, et al. , Cancer Cell, 2011 Jul 12, Volume 20, Issue 1, p.11-24, (2011)
The theoretical basis of transcriptional therapy of cancer: can it be put into practice?, Melnick, Ari M., Adelson Kerin, and Licht Jonathan D. , J Clin Oncol, 2005 Jun 10, Volume 23, Issue 17, p.3957-70, (2005)
The therapeutic landscape for cells engineered with chimeric antigen receptors., MacKay, Matthew, Afshinnekoo Ebrahim, Rub Jonathan, Hassan Ciaran, Khunte Mihir, Baskaran Nithyashri, Owens Bryan, Liu Lauren, Roboz Gail J., Guzman Monica L., et al. , Nat Biotechnol, 2020 Feb, Volume 38, Issue 2, p.233-244, (2020)
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas., Parekh, Samir, Privé Gilbert, and Melnick Ari , Leuk Lymphoma, 2008 May, Volume 49, Issue 5, p.874-82, (2008)
Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas., Polo, Jose M., Juszczynski Przemyslaw, Monti Stefano, Cerchietti Leandro, Ye Kenny, Greally John M., Shipp Margaret, and Melnick Ari , Proc Natl Acad Sci U S A, 2007 Feb 27, Volume 104, Issue 9, p.3207-12, (2007)
Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma., Verma, Akanksha, Jiang Yanwen, Du Wei, Fairchild Lauren, Melnick Ari, and Elemento Olivier , Genome Med, 2015 Nov 01, Volume 7, p.110, (2015)
Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma., Green, Michael R., Vicente-Dueñas Carolina, Romero-Camarero Isabel, Liu Chih Long, Dai Bo, González-Herrero Inés, García-Ramírez Idoia, Alonso-Escudero Esther, Iqbal Javeed, Chan Wing C., et al. , Nat Commun, 2014 Jun 02, Volume 5, p.3904, (2014)
Transitioning from fellowship to a physician-scientist career track., Melnick, Ari , Hematology Am Soc Hematol Educ Program, 2008, p.16-22, (2008)
Translocations of the RARalpha gene in acute promyelocytic leukemia., Zelent, A, Guidez F, Melnick A, Waxman S, and Licht J D. , Oncogene, 2001 Oct 29, Volume 20, Issue 49, p.7186-203, (2001)
Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling., Taskesen, Erdogan, Havermans Marije, van Lom Kirsten, Sanders Mathijs A., van Norden Yvette, Bindels Eric, Hoogenboezem Remco, Reinders Marcel J. T., Figueroa Maria E., Valk Peter J. M., et al. , Blood, 2014 May 22, Volume 123, Issue 21, p.3327-35, (2014)